Major players in the diagnostic equipment market include Philips Healthcare, Hitachi Medical Systems, Fujifilm Holdings, Siemens Healthcare, and GE Healthcare.
The global diagnostic equipment market is expected to grow from $43.81 billion in 2021 to $47.74 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The diagnostic equipment market is expected to grow to $59.46 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%.
The diagnostic devices (or) equipment market consists of sales of diagnostic equipment and related services by entities (organizations, sole traders, and partnerships) that are used to identify the nature or cause of a certain phenomenon, usually related to a medical condition. Some of the devices include magnetic resonance imaging apparatuses, temperature sensors or pacemakers.
The main types of diagnostic devices or equipment are x-rayed systems, ultrasound systems, computed tomography (ct) scanners, magnetic resonance imaging systems, cardiovascular monitoring and diagnostic devices, and nuclear imaging device. X-rays refer to a type of electromagnetic radiation, just like visible light. The mobility is stationary, and mobile and is used in hospitals, and diagnostic imaging centers.
The regions covered in diagnostic devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
An increase in the geriatric population is expected to propel the growth of the diagnostic devices market going forward. Older people are likely to suffer from diseases such as diabetes, cancer, and arthritis among others, which would increase the demand for diagnostic devices. For instance, in 2020, according to the United Nations, a US-based intergovernmental organization, there are approximately 727 million persons are aged 65 years and above worldwide, and expected to reach approximately 1.5 billion persons by 2050. Therefore, the increase in the geriatric population is driving the growth of the diagnostic devices market.
The emergence of routine diagnostic kits is a key trend gaining popularity in the diagnostic devices market. Companies operating in the market are focusing on developing diagnostic kits to gain market coverage. For instance, in March 2022, Mylab Discovery Solutions, an India-based healthcare company is set to launch an entire range of routine diagnostic kits and devices in conventional and point-of-care formats. Immunology, Biochemistry, and Haematology are the three main market sub-segments represented by the devices and kits included in them.
In July 201, DiaSorin S.p.A., an Italy-based biotechnology company acquired Luminex Corporation for a deal amount of $1.8 billion. Through the acquisition, DiaSorin would gain access to Luminex’s multiplexing technology and a portfolio that would strengthen its existing offering, while expanding the Group presence in the United States. Further, this agreement would give the Life Science sector access to Luminex's applications, promoting academic and scientific research, improving collaboration with biopharma businesses, and boosting access to clinical multiplexing assays for upcoming Value-Based Care initiatives. Luminex Corporation is a US-based biotechnology company that manufactures medical diagnostic devices.
The countries covered in the diagnostic devices or equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.
This product will be delivered within 1-3 business days.
The global diagnostic equipment market is expected to grow from $43.81 billion in 2021 to $47.74 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The diagnostic equipment market is expected to grow to $59.46 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%.
The diagnostic devices (or) equipment market consists of sales of diagnostic equipment and related services by entities (organizations, sole traders, and partnerships) that are used to identify the nature or cause of a certain phenomenon, usually related to a medical condition. Some of the devices include magnetic resonance imaging apparatuses, temperature sensors or pacemakers.
The main types of diagnostic devices or equipment are x-rayed systems, ultrasound systems, computed tomography (ct) scanners, magnetic resonance imaging systems, cardiovascular monitoring and diagnostic devices, and nuclear imaging device. X-rays refer to a type of electromagnetic radiation, just like visible light. The mobility is stationary, and mobile and is used in hospitals, and diagnostic imaging centers.
The regions covered in diagnostic devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
An increase in the geriatric population is expected to propel the growth of the diagnostic devices market going forward. Older people are likely to suffer from diseases such as diabetes, cancer, and arthritis among others, which would increase the demand for diagnostic devices. For instance, in 2020, according to the United Nations, a US-based intergovernmental organization, there are approximately 727 million persons are aged 65 years and above worldwide, and expected to reach approximately 1.5 billion persons by 2050. Therefore, the increase in the geriatric population is driving the growth of the diagnostic devices market.
The emergence of routine diagnostic kits is a key trend gaining popularity in the diagnostic devices market. Companies operating in the market are focusing on developing diagnostic kits to gain market coverage. For instance, in March 2022, Mylab Discovery Solutions, an India-based healthcare company is set to launch an entire range of routine diagnostic kits and devices in conventional and point-of-care formats. Immunology, Biochemistry, and Haematology are the three main market sub-segments represented by the devices and kits included in them.
In July 201, DiaSorin S.p.A., an Italy-based biotechnology company acquired Luminex Corporation for a deal amount of $1.8 billion. Through the acquisition, DiaSorin would gain access to Luminex’s multiplexing technology and a portfolio that would strengthen its existing offering, while expanding the Group presence in the United States. Further, this agreement would give the Life Science sector access to Luminex's applications, promoting academic and scientific research, improving collaboration with biopharma businesses, and boosting access to clinical multiplexing assays for upcoming Value-Based Care initiatives. Luminex Corporation is a US-based biotechnology company that manufactures medical diagnostic devices.
The countries covered in the diagnostic devices or equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary2. Report Structure7. Diagnostic Equipment Market Trends And Strategies21. Key Mergers And Acquisitions In The Diagnostic Equipment Market24. Copyright And Disclaimer
3. Diagnostic Equipment Market Characteristics
4. Diagnostic Equipment Market Product Analysis
5. Diagnostic Equipment Market Supply Chain
6. Diagnostic Equipment Market Customer Information
8. Diagnostic Equipment Market Size And Growth
9. Diagnostic Equipment Market Regional Analysis
10. Diagnostic Equipment Market Segmentation
11. Diagnostic Equipment Market Segments
12. Diagnostic Equipment Market Metrics
13. Asia-Pacific Diagnostic Equipment Market
14. Western Europe Diagnostic Equipment Market
15. Eastern Europe Diagnostic Equipment Market
16. North America Diagnostic Equipment Market
17. South America Diagnostic Equipment Market
18. Middle East Diagnostic Equipment Market
19. Africa Diagnostic Equipment Market
20. Diagnostic Equipment Market Competitive Landscape
22. Market Background: Medical Equipment Market
23. Recommendations
24. Appendix
25. Copyright And Disclaimer
22. Recommendations
23. Appendix
Executive Summary
Diagnostic Equipment Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global Diagnostic Equipment market.This report focuses on Diagnostic Equipment market which is experiencing strong growth. The report gives a guide to the Diagnostic Equipment market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for the Diagnostic Equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Machinery Manufacturing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Diagnostic Equipment market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The Diagnostic Equipment market section of the report gives context. It compares the Diagnostic Equipment market with other segments of the Diagnostic Equipment market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, Diagnostic Equipment indicators comparison.
Scope
Markets Covered:
1) By Type:X-Ray Systems; Ultrasound Systems; Computed Tomography (CT) Scanners; Magnetic Resonance Imaging Systems; Cardiovascular Monitoring And Diagnostic Devices; Nuclear Imaging Device.2) By Mobility: Stationary; Mobile
3) By End User: Hospitals; Diagnostic imaging centres
Companies Mentioned: Philips Healthcare; Hitachi Medical Systems; Fujifilm Holdings; Siemens Healthcare; GE Healthcare.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Philips Healthcare
- Hitachi Medical Systems
- Fujifilm Holdings
- Siemens Healthcare
- GE Healthcare.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | September 2022 |
| Forecast Period | 2022 - 2026 |
| Estimated Market Value ( USD | $ 47.74 Billion |
| Forecasted Market Value ( USD | $ 59.46 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
